250 related articles for article (PubMed ID: 30209217)
1. TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination.
Bottermann M; Foss S; van Tienen LM; Vaysburd M; Cruickshank J; O'Connell K; Clark J; Mayes K; Higginson K; Hirst JC; McAdam MB; Slodkowicz G; Hutchinson E; Kozik P; Andersen JT; James LC
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10440-10445. PubMed ID: 30209217
[TBL] [Abstract][Full Text] [Related]
2. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
Hrycak CP; Windmann S; Bayer W
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
[TBL] [Abstract][Full Text] [Related]
3. Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.
Seiler MP; Cerullo V; Lee B
Curr Gene Ther; 2007 Oct; 7(5):297-305. PubMed ID: 17979676
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of adenovirus vector expressing CTLA4-Ig prolongs transgene expression in the brain of mice sensitized with adenovirus.
Uchida T; Kajiwara K; Ideguchi M; Yoshikawa K; Morioka J; Suzuki M
Brain Res; 2001 Apr; 898(2):272-80. PubMed ID: 11306013
[TBL] [Abstract][Full Text] [Related]
5. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
Sung RS; Qin L; Bromberg JS
Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous neutralization and innate immune detection of a replicating virus by TRIM21.
Watkinson RE; Tam JC; Vaysburd MJ; James LC
J Virol; 2013 Jul; 87(13):7309-13. PubMed ID: 23596308
[TBL] [Abstract][Full Text] [Related]
7. Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy.
Wang WC; Sayedahmed EE; Mittal SK
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560730
[TBL] [Abstract][Full Text] [Related]
8. Intracellular antibody receptor TRIM21 prevents fatal viral infection.
Vaysburd M; Watkinson RE; Cooper H; Reed M; O'Connell K; Smith J; Cruickshanks J; James LC
Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12397-401. PubMed ID: 23840060
[TBL] [Abstract][Full Text] [Related]
9. Intranasal vaccination with a helper-dependent adenoviral vector enhances transgene-specific immune responses in BALB/c mice.
Fu YH; He JS; Zheng XX; Wang XB; Xie C; Shi CX; Zhang M; Tang Q; Wei W; Qu JG; Hong T
Biochem Biophys Res Commun; 2010 Jan; 391(1):857-61. PubMed ID: 19945423
[TBL] [Abstract][Full Text] [Related]
10. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
Kuzmin AI; Galenko O; Eisensmith RC
Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA silencing improves the tumor specificity of adenoviral transgene expression.
Card PB; Hogg RT; Gil Del Alcazar CR; Gerard RD
Cancer Gene Ther; 2012 Jul; 19(7):451-9. PubMed ID: 22555510
[TBL] [Abstract][Full Text] [Related]
12. TRIM21-From Intracellular Immunity to Therapy.
Foss S; Bottermann M; Jonsson A; Sandlie I; James LC; Andersen JT
Front Immunol; 2019; 10():2049. PubMed ID: 31555278
[TBL] [Abstract][Full Text] [Related]
13. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
[TBL] [Abstract][Full Text] [Related]
14. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.
Mack CA; Song WR; Carpenter H; Wickham TJ; Kovesdi I; Harvey BG; Magovern CJ; Isom OW; Rosengart T; Falck-Pedersen E; Hackett NR; Crystal RG; Mastrangeli A
Hum Gene Ther; 1997 Jan; 8(1):99-109. PubMed ID: 8989999
[TBL] [Abstract][Full Text] [Related]
15. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues.
Yang Y; Su Q; Grewal IS; Schilz R; Flavell RA; Wilson JM
J Virol; 1996 Sep; 70(9):6370-7. PubMed ID: 8709265
[TBL] [Abstract][Full Text] [Related]
16. Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.
Lopez-Gordo E; Podgorski II; Downes N; Alemany R
Hum Gene Ther; 2014 Apr; 25(4):285-300. PubMed ID: 24499174
[TBL] [Abstract][Full Text] [Related]
17. NKG2D is required for NK cell activation and function in response to E1-deleted adenovirus.
Zhu J; Huang X; Yang Y
J Immunol; 2010 Dec; 185(12):7480-6. PubMed ID: 21076062
[TBL] [Abstract][Full Text] [Related]
18. Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells.
Bidgood SR; Tam JC; McEwan WA; Mallery DL; James LC
Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13463-8. PubMed ID: 25169018
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen.
Qin L; Ding Y; Pahud DR; Robson ND; Shaked A; Bromberg JS
Hum Gene Ther; 1997 Jul; 8(11):1365-74. PubMed ID: 9295131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
